BTAX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BTAX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.
Biostax's adjusted revenue per share for the three months ended in Sep. 2024 was $0.000. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Sep. 2024.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.
As of today (2025-05-15), Biostax's current stock price is $0.0002. Biostax's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was $0.00. Biostax's Cyclically Adjusted PS Ratio of today is .
The historical data trend for Biostax's Cyclically Adjusted Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biostax Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Cyclically Adjusted Revenue per Share | Get a 7-Day Free Trial |
![]() |
![]() |
- | - | - | - | - |
Biostax Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Cyclically Adjusted Revenue per Share | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
- | - | - | - | - |
For the Biotechnology subindustry, Biostax's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Biostax's Cyclically Adjusted PS Ratio distribution charts can be found below:
* The bar in red indicates where Biostax's Cyclically Adjusted PS Ratio falls into.
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.
What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?
Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.
If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.
We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
For example, Biostax's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:
Adj_RevenuePerShare | = | Revenue per Share | / | CPI of Sep. 2024 (Change) | * | Current CPI (Sep. 2024) |
= | 0 | / | 133.0289 | * | 133.0289 | |
= | 0.000 |
Current CPI (Sep. 2024) = 133.0289.
Biostax Quarterly Data
Revenue per Share | CPI | Adj_RevenuePerShare | |
201412 | 0.000 | 99.070 | 0.000 |
201503 | 0.014 | 99.621 | 0.019 |
201506 | 0.041 | 100.684 | 0.054 |
201509 | 0.032 | 100.392 | 0.042 |
201512 | 0.023 | 99.792 | 0.031 |
201603 | 0.016 | 100.470 | 0.021 |
201606 | 0.000 | 101.688 | 0.000 |
201609 | 0.000 | 101.861 | 0.000 |
201612 | 0.000 | 101.863 | 0.000 |
201703 | 0.000 | 102.862 | 0.000 |
201706 | 0.000 | 103.349 | 0.000 |
201709 | 0.000 | 104.136 | 0.000 |
201712 | 0.000 | 104.011 | 0.000 |
201803 | 0.168 | 105.290 | 0.212 |
201806 | 0.000 | 106.317 | 0.000 |
201809 | 0.000 | 106.507 | 0.000 |
201812 | 0.091 | 105.998 | 0.114 |
201903 | 0.000 | 107.251 | 0.000 |
201906 | 0.000 | 108.070 | 0.000 |
201909 | 0.000 | 108.329 | 0.000 |
201912 | 0.000 | 108.420 | 0.000 |
202003 | 0.000 | 108.902 | 0.000 |
202006 | 0.000 | 108.767 | 0.000 |
202009 | 0.000 | 109.815 | 0.000 |
202012 | 0.000 | 109.897 | 0.000 |
202103 | 0.000 | 111.754 | 0.000 |
202106 | 0.000 | 114.631 | 0.000 |
202109 | 0.000 | 115.734 | 0.000 |
202112 | 0.000 | 117.630 | 0.000 |
202203 | 0.000 | 121.301 | 0.000 |
202206 | 0.000 | 125.017 | 0.000 |
202209 | 0.000 | 125.227 | 0.000 |
202212 | 0.000 | 125.222 | 0.000 |
202303 | 0.000 | 127.348 | 0.000 |
202306 | 0.000 | 128.729 | 0.000 |
202309 | 0.000 | 129.860 | 0.000 |
202312 | 0.000 | 129.419 | 0.000 |
202403 | 0.000 | 131.776 | 0.000 |
202406 | 0.000 | 132.554 | 0.000 |
202409 | 0.000 | 133.029 | 0.000 |
Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.
Biostax (OTCPK:BTAX) Cyclically Adjusted Revenue per Share Explanation
If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.
For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.
Be Aware
Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.
Thank you for viewing the detailed overview of Biostax's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Glen A Farmer | officer: Chief Financial Officer | 20358 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876 |
H. Louis Salomonsky Jr. Revocable Trust | 10 percent owner | 2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792 |
Henry Louis Salomonsky | director, 10 percent owner | 2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792 |
Kelly O'brien Wilson | 10 percent owner, officer: COO and ICEO and IP | 2431 ALOMA AVE, SUITE 124, WINTER PARK FL 32792 |
James Norman Curley | other: Member of 10% owner group | 410 DAHLIA AVE, CORONA DEL MAR CA 92625 |
Empower Insurance Corp Ltd | other: Member of 10% owner group | 1254 LEEWARD HIGHWAY, 4 CARIBBEAN PLACE, PROVIDENCIALES W7 TKCA1ZZ |
Global Reverb Corp | 10 percent owner, other: Member of 10% owner group | 100 S EOLA DR, UNIT 1703, ORLANDO FL 32801 |
Paul Puskadi | other: Member of 10% owner group | 2020 TIGERTAIL BLVD, 7A, DANIA BEACH FL 33004 |
Deane Rhodes | other: Member of 10% owner group | 9200 HALSEY CIRCLE NE, TUSCALOOSA AL 35406 |
Roger Dale Bozarth | other: Member of 10% owner group | 9028 GREAT HERON CIR, ORLANDO FL 32836 |
Joel Yanowitz | other: Member of 10% owner group | 100 TAMAL PLZ, SUITE 106, CORTE MADERA CA 94925 |
Rogoff Family Trust Dtd | other: Member of 10% owner group | 20701 N SCOTTSDALE DR, ST 107-501, SCOTTSDALE AZ 85255 |
George Sasko | other: Member of 10% owner group | 515 WESTCHESTER DR, STE D, CAMPBELL CA 95008 |
Raster Investments, Inc | other: Member of 10% owner group | 2384 ORCHARD CREST BLVD, MANASQUAN NJ 08736 |
Robert Jackman Dailey | other: Member of 10% owner group | 401 FIRST STREET, LOS ALTOS CA 94022 |
From GuruFocus
By Marketwired Marketwired • 09-06-2018
By Marketwired Marketwired • 03-26-2018
By Marketwired Marketwired • 05-15-2019
By Marketwired Marketwired • 06-05-2018
By Marketwired Marketwired • 06-05-2018
By Marketwired Marketwired • 07-25-2018
By Marketwired Marketwired • 12-13-2018
By Marketwired Marketwired • 09-26-2019
By Marketwired Marketwired • 09-23-2019
By Marketwired Marketwired • 09-05-2018
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.